Liposomal amphotericin B standard dose in combination with caspofungin versus liposomal amphotericin B high dose regimen for the treatment of invasive aspergillosis in immunocompromised patients:: randomised pilot study (Combistrat Trial)

被引：0
|
作者：
Caillot, D.
Thiebaut, A.
Herbrecht, R.
Pigneux, A.
de Botton, S.
Attal, M.
Bernard, F.
Larche, J.
Alfandari, S.
Monchecourt, F.
Mahi, L.
机构：
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0924-8579(07)70821-X
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [41] Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy
    Lane, Jason W.
    Rehak, Nadja N.
    Hortin, Glen L.
    Zaoutis, Theoklis
    Krause, Philip R.
    Walsh, Thomas J.
    CLINICA CHIMICA ACTA, 2008, 387 (1-2) : 145 - 149
  • [42] High dose liposomal amphotericin-B therapy for rhinocerebral mucormycosis
    Aydogan, G
    Akcay, A
    Turhan, P
    Salcioglu, Z
    Akici, F
    Ayaz, NA
    Onal, H
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 161 - 166
  • [43] Pseudohypophosphatemia associated with high-dose liposomal amphotericin B therapy
    Mays, James A.
    Greene, Dina N.
    Poon, Anne
    Merrill, Anna E.
    CLINICAL BIOCHEMISTRY, 2017, 50 (16-17) : 967 - 971
  • [44] Does the combination of liposomal amphotericin B and echinocandins improve the survival of patients having invasive aspergillosis in hematology?
    Suarez, Felipe
    HEMATOLOGIE, 2011, 17 (01): : 19 - 20
  • [45] Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients
    Cagnoni, PJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 : 81 - 86
  • [46] A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever
    Ellis, Michael
    Bernsen, Roos
    Ali-Zadeh, Hussein
    Kristensen, Joergen
    Hedstrom, Ulla
    Poughias, Lazaros
    Bresnik, Mark
    Al-Essa, Awad
    Stevens, David A.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (11) : 1474 - 1485
  • [47] COST COMPARISON OF LIPOSOMAL AMPHOTERICIN B VS CASPOFUNGIN FOR THE EMPIRICAL TREATMENT OF INVASIVE FUNGAL INFECTIONS
    Malyszczak, W.
    Jones, B. L.
    Jackson, B.
    Malyszczak, W.
    Agrawal, S.
    Jensen, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 321 - 321
  • [48] Cost-effectiveness of voriconazole versus liposomal amphotericin B for invasive aspergillosis infection in the UK
    Mesrobian, X
    Loftus, J
    Roberts, C
    Jansen, J
    VALUE IN HEALTH, 2005, 8 (06) : A20 - A20
  • [49] Vertebral infection with Candida albicans failing caspofungin and fluconazole combination therapy but successfully treated with high dose liposomal amphotericin B and flucytosine
    Storm, Line
    Lausch, Karen R.
    Arendrup, Maiken C.
    Mortensen, Klaus L.
    Petersen, Eskild
    MEDICAL MYCOLOGY CASE REPORTS, 2014, 6 : 6 - 9
  • [50] High-Dose Liposomal Amphotericin B in the Therapy of Systemic Candidiasis in Neonates
    A. Juster-Reicher
    O. Flidel-Rimon
    M. Amitay
    S. Even-Tov
    E. Shinwell
    E. Leibovitz
    European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 603 - 607
12345